Abstract

Prevalence of phantom limb pain remain high up to this day, 50%-80%. Lack of treatment response makes PLP a challenge condition up to this day, as the mechanism of PLP is not clearly known yet. Therefore, a review of all available literature is warranted. From all treatment modalities, no one gives optimum-long term result, so now we concern to the prevention of PLP such as reducing pre-amputation pain and acute pain following amputation. Further randomized, double-blind, controlled trial study with more adequate samples.

Key words: phantom limp pain, management of phantom limb pain, pharmacologic therapy, nonpharmacologic therapy